Literature DB >> 19913916

Staphylococcal superantigen-like protein 10 (SSL10) binds to human immunoglobulin G (IgG) and inhibits complement activation via the classical pathway.

Saotomo Itoh1, Eri Hamada, Go Kamoshida, Ryosuke Yokoyama, Takemasa Takii, Kikuo Onozaki, Tsutomu Tsuji.   

Abstract

Staphylococcal superantigen-like (SSL) proteins are a family of exoproteins that share structural similarity with staphylococcal superantigens but exhibit no superantigenic activity. It was previously reported that two members (SSL5 and SSL7) bound to serum components and cell adhesion molecules involved in host immune response; however, the other family members have not been functionally characterized. In this study, we attempted to isolate SSL10-binding proteins from human serum and found that recombinant His-tagged SSL10 bound two major polypeptides of approximately 50 and approximately 25 kDa after affinity purification and SDS-polyacrylamide gel electrophoresis. These polypeptides were identified as heavy and light chains of human IgG by peptide mass fingerprinting analysis. The specific interaction between recombinant SSL10 and human IgG was confirmed by far Western blot analysis using immobilized SSL10 and pull-down analysis using SSL10-conjugated Sepharose. Surface plasmon resonance analysis revealed that the dissociation equilibrium constant for the interaction between human IgG and recombinant SSL10 was estimated to be 220 nM. We also found that recombinant SSL10 inhibited the binding of complement component C1q to IgG-Sepharose and hemolysis of IgG-sensitized sheep erythrocytes via the classical complement activation pathway. These results suggest that SSL10 may play a role in the evasion of Staphylococcus aureus from the host immune system via interfering complement activation. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19913916     DOI: 10.1016/j.molimm.2009.09.027

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  23 in total

1.  Staphylococcal superantigen-like protein 3 binds to the Toll-like receptor 2 extracellular domain and inhibits cytokine production induced by Staphylococcus aureus, cell wall component, or lipopeptides in murine macrophages.

Authors:  Ryosuke Yokoyama; Saotomo Itoh; Go Kamoshida; Takemasa Takii; Satoshi Fujii; Tsutomu Tsuji; Kikuo Onozaki
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

2.  Molecular mechanisms of complement evasion: learning from staphylococci and meningococci.

Authors:  Davide Serruto; Rino Rappuoli; Maria Scarselli; Piet Gros; Jos A G van Strijp
Journal:  Nat Rev Microbiol       Date:  2010-06       Impact factor: 60.633

3.  Structural basis for inhibition of TLR2 by staphylococcal superantigen-like protein 3 (SSL3).

Authors:  Kirsten J Koymans; Louris J Feitsma; T Harma C Brondijk; Piet C Aerts; Eddie Lukkien; Philip Lössl; Kok P M van Kessel; Carla J C de Haas; Jos A G van Strijp; Eric G Huizinga
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

4.  Collagen-binding microbial surface components recognizing adhesive matrix molecule (MSCRAMM) of Gram-positive bacteria inhibit complement activation via the classical pathway.

Authors:  Mingsong Kang; Ya-Ping Ko; Xiaowen Liang; Caná L Ross; Qing Liu; Barbara E Murray; Magnus Höök
Journal:  J Biol Chem       Date:  2013-05-29       Impact factor: 5.157

Review 5.  Targeting fundamental pathways to disrupt Staphylococcus aureus survival: clinical implications of recent discoveries.

Authors:  Isaac P Thomsen; George Y Liu
Journal:  JCI Insight       Date:  2018-03-08

6.  Staphylococcus aureus regulates the expression and production of the staphylococcal superantigen-like secreted proteins in a Rot-dependent manner.

Authors:  Meredith A Benson; Sarit Lilo; Gregory A Wasserman; Matthew Thoendel; Amanda Smith; Alexander R Horswill; John Fraser; Richard P Novick; Bo Shopsin; Victor J Torres
Journal:  Mol Microbiol       Date:  2011-06-16       Impact factor: 3.501

7.  Evasion of Toll-like receptor 2 activation by staphylococcal superantigen-like protein 3.

Authors:  B W Bardoel; R Vos; T Bouman; P C Aerts; J Bestebroer; E G Huizinga; T H C Brondijk; J A G van Strijp; C J C de Haas
Journal:  J Mol Med (Berl)       Date:  2012-06-20       Impact factor: 4.599

Review 8.  Interaction of host and Staphylococcus aureus protease-system regulates virulence and pathogenicity.

Authors:  Vigyasa Singh; Ujjal Jyoti Phukan
Journal:  Med Microbiol Immunol       Date:  2018-11-27       Impact factor: 3.402

9.  The Staphylococcus aureus polysaccharide capsule and Efb-dependent fibrinogen shield act in concert to protect against phagocytosis.

Authors:  Annemarie Kuipers; Daphne A C Stapels; Lleroy T Weerwind; Ya-Ping Ko; Maartje Ruyken; Jean C Lee; Kok P M van Kessel; Suzan H M Rooijakkers
Journal:  Microbiology (Reading)       Date:  2016-04-25       Impact factor: 2.777

10.  Staphylococcal superantigen-like protein 10 (SSL10) inhibits blood coagulation by binding to prothrombin and factor Xa via their γ-carboxyglutamic acid (Gla) domain.

Authors:  Saotomo Itoh; Ryosuke Yokoyama; Go Kamoshida; Toshinobu Fujiwara; Hiromi Okada; Takemasa Takii; Tsutomu Tsuji; Satoshi Fujii; Hideki Hashizume; Kikuo Onozaki
Journal:  J Biol Chem       Date:  2013-06-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.